(Q26865747)

English

Systematic review with meta-analysis: do interferon lambda 3 polymorphisms predict the outcome of interferon-therapy in hepatitis B infection?

scientific article

In more languages

Statements

scholarly article

2 references

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461198%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

Systematic review with meta-analysis: do interferon lambda 3 polymorphisms predict the outcome of interferon-therapy in hepatitis B infection? (English)

2 references

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461198%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Pietro Lampertico

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461198%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

E Galmozzi

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461198%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

M Viganò

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461198%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

language of work or name

1 reference

publication date

26 January 2014

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461198%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Alimentary Pharmacology & Therapeutics

2 references

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461198%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

39

2 references

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461198%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

6

2 references

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461198%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

569-578

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461198%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Chronic hepatitis B infection.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12631

21 January 2018

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12631

21 January 2018

Chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12631

21 January 2018

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12631

21 January 2018

Antiviral drugs for HBV liver disease.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12631

21 January 2018

Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12631

21 January 2018

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12631

21 January 2018

Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12631

21 January 2018

Shorter durations and lower doses of peginterferon alfa-2a are associated with inferior hepatitis B e antigen seroconversion rates in hepatitis B virus genotypes B or C.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12631

21 January 2018

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12631

21 January 2018

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12631

21 January 2018

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12631

21 January 2018

Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12631

21 January 2018

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12631

21 January 2018

Current status and prospects of studies on human genetic alleles associated with hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12631

21 January 2018

A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12631

21 January 2018

Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12631

21 January 2018

A genome-wide association study with DNA pooling identifies the variant rs11866328 in the GRIN2A gene that affects disease progression of chronic HBV infection

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12631

21 January 2018

A common HLA-DPA1 variant is a major determinant of hepatitis B virus clearance in Han Chinese.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12631

21 January 2018

Associations of HLA-DP variants with hepatitis B virus infection in southern and northern Han Chinese populations: a multicenter case-control study

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12631

21 January 2018

Evaluation of genetic susceptibility loci for chronic hepatitis B in Chinese: two independent case-control studies

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12631

21 January 2018

Host genetic factors affecting spontaneous HBsAg seroclearance in chronic hepatitis B patients

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12631

21 January 2018

HLA-DP and IL28B polymorphisms: influence of host genome on hepatitis B surface antigen seroclearance in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12631

21 January 2018

Association of HLA and TNF polymorphisms with the outcome of HBV infection in the South Indian population

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12631

21 January 2018

Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12631

21 January 2018

Evaluation of susceptibility locus for response to interferon-α based therapy in chronic hepatitis B patients in Chinese.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12631

21 January 2018

IL28B polymorphisms predict interferon-related hepatitis B surface antigen seroclearance in genotype D hepatitis B e antigen-negative patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12631

21 January 2018

Combined effects of different interleukin-28B gene variants on the outcome of dual combination therapy in chronic hepatitis C virus type 1 infection.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12631

21 January 2018

IL28B genotype is not useful for predicting treatment outcome in Asian chronic hepatitis B patients treated with pegylated interferon-α.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12631

21 January 2018

Genetic variation in IL28B and treatment outcome in HBeAg-positive and -negative chronic hepatitis B patients treated with Peg interferon alfa-2a and adefovir.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12631

21 January 2018

Relationship between HLA-DP gene polymorphisms and clearance of chronic hepatitis B virus infections: case-control study and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12631

21 January 2018

Association of the rs3077 and rs9277535 polymorphisms in HLA-DP with hepatitis B virus infection and spontaneous clearance: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12631

21 January 2018

Polymorphisms Near IL28B and Serologic Response to Peginterferon in HBeAg-Positive Patients With Chronic Hepatitis B

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12631

21 January 2018

Identifiers

10.1111/APT.12631

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461198%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461198%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q26865747&oldid=1950504143"